183 related articles for article (PubMed ID: 12447672)
1. Clonality and K-ras mutation analyses of epithelia in intraductal papillary mucinous tumor and mucinous cystic tumor of the pancreas.
Yoshizawa K; Nagai H; Sakurai S; Hironaka M; Morinaga S; Saitoh K; Fukayama M
Virchows Arch; 2002 Nov; 441(5):437-43. PubMed ID: 12447672
[TBL] [Abstract][Full Text] [Related]
2. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas.
Wada K
J Hepatobiliary Pancreat Surg; 2002; 9(1):76-85. PubMed ID: 12021900
[TBL] [Abstract][Full Text] [Related]
3. Clonality and field cancerization in intraductal papillary-mucinous tumors of the pancreas.
Izawa T; Obara T; Tanno S; Mizukami Y; Yanagawa N; Kohgo Y
Cancer; 2001 Oct; 92(7):1807-17. PubMed ID: 11745253
[TBL] [Abstract][Full Text] [Related]
4. K-Ras and microsatellite marker analysis of fine-needle aspirates from intraductal papillary mucinous neoplasms of the pancreas.
Schoedel KE; Finkelstein SD; Ohori NP
Diagn Cytopathol; 2006 Sep; 34(9):605-8. PubMed ID: 16900481
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations in adenoma-carcinoma sequencing of intraductal papillary-mucinous neoplasm of the pancreas.
Nakata B; Yashiro M; Nishioka N; Aya M; Yamada S; Takenaka C; Ohira M; Ishikawa T; Nishino H; Wakasa K; Hirakawa K
Int J Oncol; 2002 Nov; 21(5):1067-72. PubMed ID: 12370756
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
Uemura K; Hiyama E; Murakami Y; Kanehiro T; Ohge H; Sueda T; Yokoyama T
Oncol Rep; 2003; 10(2):277-83. PubMed ID: 12579258
[TBL] [Abstract][Full Text] [Related]
7. Single-pattern convergence of K-ras mutation correlates with surgical indication of intraductal papillary mucinous neoplasms.
Mizuno O; Kawamoto H; Yamamoto N; Horiguchi S; Tsutsumi K; Fujii M; Kato H; Hirao K; Kurihara N; Ishida E; Ogawa T; Okada H; Yamamoto K
Pancreas; 2010 Jul; 39(5):617-21. PubMed ID: 20173673
[TBL] [Abstract][Full Text] [Related]
8. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G
Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563
[TBL] [Abstract][Full Text] [Related]
9. Increased K-ras mutation and expression of S100A4 and MUC2 protein in the malignant intraductal papillary mucinous tumor of the pancreas.
Jang JY; Park YC; Song YS; Lee SE; Hwang DW; Lim CS; Lee HE; Kim WH; Kim SW
J Hepatobiliary Pancreat Surg; 2009; 16(5):668-74. PubMed ID: 19412570
[TBL] [Abstract][Full Text] [Related]
10. Progressive genomic alterations in intraductal papillary mucinous tumours of the pancreas and morphologically similar lesions of the pancreatic ducts.
Soldini D; Gugger M; Burckhardt E; Kappeler A; Laissue JA; Mazzucchelli L
J Pathol; 2003 Apr; 199(4):453-61. PubMed ID: 12635136
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
[TBL] [Abstract][Full Text] [Related]
12. Comparison of K-ras point mutation distributions in intraductal papillary-mucinous tumors and ductal adenocarcinoma of the pancreas.
Kitago M; Ueda M; Aiura K; Suzuki K; Hoshimoto S; Takahashi S; Mukai M; Kitajima M
Int J Cancer; 2004 Jun; 110(2):177-82. PubMed ID: 15069678
[TBL] [Abstract][Full Text] [Related]
13. P53 mutation but not p16/MTS1 mutation occurs in intraductal papillary mucinous tumors of the pancreas.
Mueller J; Gansauge S; Mattfeldt T
Hepatogastroenterology; 2003; 50(50):541-4. PubMed ID: 12749268
[TBL] [Abstract][Full Text] [Related]
14. Invasive cancer and survival of intraductal papillary mucinous tumors of the pancreas.
Raimondo M; Tachibana I; Urrutia R; Burgart LJ; DiMagno EP
Am J Gastroenterol; 2002 Oct; 97(10):2553-8. PubMed ID: 12385438
[TBL] [Abstract][Full Text] [Related]
15. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
Adsay NV; Basturk O; Cheng JD; Andea AA
Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
[TBL] [Abstract][Full Text] [Related]
16. Characterization of K-ras gene mutations in association with mucinous hypersecretion in intraductal papillary-mucinous neoplasms.
Kobayashi N; Inamori M; Fujita K; Fujisawa T; Fujisawa N; Takahashi H; Yoneda M; Abe Y; Kawamura H; Shimamura T; Kirikoshi H; Kubota K; Sakaguchi T; Saito S; Saubermann LJ; Nakajima A
J Hepatobiliary Pancreat Surg; 2008; 15(2):169-77. PubMed ID: 18392710
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of molecular biological factors in intraductal papillary-mucinous tumors and mucinous cystic tumors of the pancreas.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Tanaka M; Manabe T
Scand J Gastroenterol; 2004 Nov; 39(11):1159-65. PubMed ID: 15545177
[TBL] [Abstract][Full Text] [Related]
18. Intraductal papillary-mucinous tumors of the pancreas.
Kubosawa H; Uehara T; Watanabe Y; Urashima T; Matsubara H; Asano T; Ochiai T
Hepatogastroenterology; 2004; 51(59):1489-94. PubMed ID: 15362784
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic mucinous cystic neoplasms with sarcomatous stroma: molecular evidence for monoclonal origin with subsequent divergence of the epithelial and sarcomatous components.
van den Berg W; Tascilar M; Offerhaus GJ; Albores-Saavedra J; Wenig BM; Hruban RH; Gabrielson E
Mod Pathol; 2000 Jan; 13(1):86-91. PubMed ID: 10658914
[TBL] [Abstract][Full Text] [Related]
20. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.
Michaels PJ; Brachtel EF; Bounds BC; Brugge WR; Pitman MB
Cancer; 2006 Jun; 108(3):163-73. PubMed ID: 16550572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]